WuXi AppTec Co., Ltd. (WUXIF)

OTCMKTS · Delayed Price · Currency is USD
3.780
0.00 (0.00%)
Oct 30, 2024, 4:00 PM EDT
-70.21%
Market Cap 20.83B
Revenue (ttm) 5.49B
Net Income (ttm) 1.15B
Shares Out n/a
EPS (ttm) 0.39
PE Ratio n/a
Forward PE n/a
Dividend 0.14 (3.68%)
Ex-Dividend Date Jun 17, 2024
Volume 39
Open 6.160
Previous Close n/a
Day's Range 3.780 - 6.160
52-Week Range 3.740 - 12.690
Beta 0.83
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 41,116
Stock Exchange OTCMKTS
Ticker Symbol WUXIF
Full Company Profile

Financial Performance

In 2023, WuXi AppTec's revenue was 40.34 billion, an increase of 2.51% compared to the previous year's 39.35 billion. Earnings were 9.61 billion, an increase of 9.00%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.